Translated title. Original: La IA impulsa inversiones extremas
The article notes a renewed investor focus on neurotechnology, particularly brain-computer interfaces, as capital returns to expensive, high-risk science projects. It highlights Neuralink and Precision Neuroscience as examples, compares surgical and non-surgical approaches, and discusses the ongoing gap between proven capability and clinical-ready, affordable treatments.
Precision Neuroscience secures $250 million to push a minimally invasive cortical brain-computer interface, backed by a thin-film electrode approach. The round signals growing investor interest in scalable clinical and regulatory paths, as competition in the BCI field intensifies beyond early proofs of concept.
Neuralink's public materials outline investigational brain-computer interface hardware and early trials, with aims to enable paralyzed users to control devices and, long term, serve as a broad input-output platform; milestones, regulatory steps, and controversy are noted but not resolved in the source.
Translated title. Original: Илон Маск объявил о создании импланта для восстановления зрения слепым
Neuralink reports progress on a brain implant (Blindsight) to restore sight by directly stimulating the brain, with regulatory approval pending; Elon Musk also references Telepathy and potential epilepsy applications, while related reports mention prior implants and a separate company involved in retinal implants.
Neuralink is testing a brain-implant in paralysed participants across three countries. The device reads brain signals to move a cursor, type, or control a robotic arm, but it is not yet approved for sale. Enrollment numbers, trial statuses, and funding details are reported, with results including a best cursor speed of 11.32 bits/sec, and ongoing demonstrations in speech and vision programs with unclear published results.
Translated title. Original: Neuralink desarrolla los implantes Telepathy y Blindsight - Root-Nation.com
Neuralink is developing two brain-implant devices, Telepathy for computer control by thought and Blindsight for bypassing damaged vision. Both aim to restore function after injury or disease, with regulatory approvals and clinical trials ahead; Blindsight received FDA Breakthrough Device designation, signaling accelerated review but not approval.
Neuralink introduces Telepathy and Blindsight, two brain-implant projects aimed at restoring mobility and vision. Telepathy uses neural signals to control devices, while Blindsight bypasses damaged eyes by feeding visual data to the cortex; both awaiting regulatory clearance, with Blindsight having FDA Breakthrough status as of September 2024.
Translated title. Original: Was ist Neuralink Telepathy?
Neuralink presents Telepathy as a software-hardware system to control devices via thought, using an implanted N1 device with facially thin brain threads. The work is in clinical feasibility studies, not approved, with ongoing trials and expanding participant numbers; reported technical milestones include cursor control in bits per second and planned features, but no regulatory approval yet.
Translated title. Original: Elon Musk veut redonner la vue aux aveugles : voici le nouvel implant révolutionnaire que Neuralink a développé
Neuralink, led by Elon Musk, has existing brain-implant technology that helps paralysed individuals control devices and communicate via thought-to-speech. The company is pursuing Blindsight to restore vision, claiming engineering readiness but awaiting regulatory approval to proceed.
Translated title. Original: Neuralink : Telepathy et Blindsight, les ambitions d’Elon Musk
Elon Musk's Neuralink outlines Telepathy and Blindsight, two implant concepts to restore movement and vision via brain-machine interfaces; Telepathy aims at paralytics, Blindsight at blindness, with regulatory steps and long-term safety still uncertain.